BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5074533)

  • 21. Effect of oxyphenbutazone on concentration of penicillin in serum.
    Frisk AR; Tunevall G
    Experientia; 1972 Mar; 28(3):296-7. PubMed ID: 5026440
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetics of warfarin absorption in man.
    Breckenridge A; Orme M
    Clin Pharmacol Ther; 1973; 14(6):955-61. PubMed ID: 4584153
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
    Jähnchen E; Levy G
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
    [No Abstract]   [Full Text] [Related]  

  • 25. Sodium warfarin.
    O'Reilly RA
    Pharmacology; 1972; 8(1):181-90. PubMed ID: 4644647
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].
    Rupp W; Christ O; Heptner W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1428-34. PubMed ID: 5394466
    [No Abstract]   [Full Text] [Related]  

  • 27. Propylthiouracil: absorption, metabolism and excretion in the albino rat.
    Sitar DS; Thornhill DP
    J Pharmacol Exp Ther; 1972 Nov; 183(2):440-8. PubMed ID: 5083555
    [No Abstract]   [Full Text] [Related]  

  • 28. Biliary excretion of warfarin metabolites and their metabolism by rat gut flora.
    Powell ML; Pope B; Elmer GW; Trager WF
    Life Sci; 1977 Jan; 20(1):171-7. PubMed ID: 13258
    [No Abstract]   [Full Text] [Related]  

  • 29. The biochemistry of warfarin resistance in the rat.
    Davis RJ; Davies BH
    Biochem J; 1970 Jul; 118(3):44P-45P. PubMed ID: 5472172
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of phenylbutazone and oxyphenbutazone on gastric acid production].
    Hemmati A
    Arzneimittelforschung; 1969 Jul; 19(7):1130-2. PubMed ID: 5394515
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tienilic acid (Diflurex) on the binding of warfarin 14C to human plasma proteins.
    Prandota J; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):158-62. PubMed ID: 7380589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of BSP and rifamycin on the excretion of warfarin in the bile of the rate.
    Wosilait WD
    Gen Pharmacol; 1977; 8(5-6):349-53. PubMed ID: 604160
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of broad-spectrum antibiotics on warfarin excretion and metabolism in the rat.
    Remmel RP; Elmer GW
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):503-14. PubMed ID: 7323446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the intestinal microflora on the elimination of warfarin in the rat.
    Remmel RP; Pohl LR; Elmer GW
    Drug Metab Dispos; 1981; 9(5):410-4. PubMed ID: 6117438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.